Showing results (311-320 of 347) with videos related to

Sort By:
Pageof 35
Rivista Di Neurologia|November 1, 1991
[Changes in the nigrostriatal dopamine receptor compartment after continuous dopaminergic infusions in Parkinson disease]F Baronti, S Ruggieri, M M Mouradian, et al.
Cephalalgia : an International Journal of Headache|August 1, 1983
Post-traumatic headache: neuropsychological and clinical aspectsM Fioravanti, L Ramelli, A Napoleoni, et al.
The Journal of Pediatrics|November 1, 1995
Final height after long-term growth hormone treatment in Turner syndrome. European Study GroupJ Van den Broeck, G G Massa, A Attanasio, et al.
Annals of the New York Academy of Sciences|July 10, 2002
Morphological and biochemical evidence that apomorphine rescues striatal dopamine terminals and prevents methamphetamine toxicityG Battaglia, M Gesi, P Lenzi, et al.
Neuropharmacology|March 19, 2002
Continuous subcutaneous infusion of apomorphine rescues nigro-striatal dopaminergic terminals following MPTP injection in miceG Battaglia, C L Busceti, L Cuomo, et al.
Parkinsonism & Related Disorders|October 2, 2014
Characterizing motor and non-motor aspects of early-morning off periods in Parkinson's disease: an international multicenter studyA Rizos, P Martinez-Martin, P Odin, et al.
Clinical Genetics|August 17, 2000
Atypical movement disorders in the early stages of Huntington's disease: clinical and genetic analysisF Squitieri, A Berardelli, E Nargi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 5, 2003
Continuous apomorphine infusion and neuropsychiatric disorders: a controlled study in patients with advanced Parkinson's diseaseA E Di Rosa, A Epifanio, A Antonini, et al.
Neurology|October 22, 1998
Direct genetic evidence for involvement of tau in progressive supranuclear palsy. European Study Group on Atypical Parkinsonism ConsortiumP Bennett, V Bonifati, U Bonuccelli, et al.
Archives of Gerontology and Geriatrics. Supplement|June 23, 2004
Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: a follow-up of two yearsL Morgante, G Basile, A Epifanio, et al.
Pageof 35